N'isi August, INNOVITA 2019-nCoV antigen akwadoro site na French National Drug and Health Product Safety Agency (ANSM) na Thailand Food and Drug Administration (Thai FDA), ka ọ na-erule mgbe ahụ, INNOVITA Covid-19 edebanyela ule n'ihe fọrọ nke nta ka ọ bụrụ 30. mba.
Mba ndị a gụnyere China, United States, Brazil, France, Italy, Russia, Spain, Portugal, Netherlands, Hungary, Austria, Sweden, Singapore, Philippines, Malaysia, Thailand, Argentina, Ecuador, Colombia, Peru, Chile, Mexico. Ugbu a, INNOVITA na-etinyekwa akwụkwọ maka asambodo CE na ndebanye aha US FDA COVID-19 antigen test, iji mee ka mgbasawanye nke ndebanye aha esenidụt nke ngwa ule COVID-19.
Mgbe ebupụchara ya na mba ndị dị n'elu, INNOVITA na-enye nyocha ziri ezi, ngwa ngwa na nnukwu nyocha nke ọrịa COVID-19 arụwo ọrụ dị mkpa na ọgụ megide COVID-19 na obodo ọ bụla.
Mgbe ntiwapụ nke COVID-19 na 2020, INNOVITA zara ngwa ngwa wee ziga ndị ọrụ R&D ama ama ka ha mee nyocha sayensị ehihie na abalị, wee mepụta ngwa nyocha coronavirus ọhụrụ (2019-nCoV) nke ọma wee kwado ya NMPA.INNOVITA so na ụlọ ọrụ mbụ na China nwetara akwụkwọ ndebanye aha nke ngwa nnwale mgbochi COVID-19.A na-ere ngwaahịa ndị a nke ọma ma n'ime ụlọ na mba ọzọ, na-enye aka dị ukwuu n'ịlụso ọrịa a ọgụ.Na Septemba 2020, enwetara INNOVITA “National Advanced Collective” na ọgbakọ otuto mba maka ịlụso ọrịa COVID-19 ọgụ.Na Jenụwarị 26 2021, Ministri Sayensị na Teknụzụ zigakwara INNOVITA akwụkwọ ozi ekele maka nkwado na ọrụ nyocha ihe mberede iji lụso ọrịa a ọgụ.
N'ọdịniihu, INNOVITA ga-aga n'ihu na-eji uru teknụzụ ya na ịdị mma ya dị mma, nyochaa ahịa zuru ụwa ọnụ ma nye aka China Ike na ịlụso ọrịa a ọgụ n'ụwa niile!
Oge nzipu: Ọktoba 18-2021